BioMarin Pharmaceuticals BMRN Ireland — Total long-lived assets
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NoncurrentAssets.
The official record: BioMarin Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioMarin Pharmaceuticals's ireland — total long-lived assets.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioMarin Pharmaceuticals's ireland — total long-lived assets?
- BioMarin Pharmaceuticals (BMRN) reported ireland — total long-lived assets of $331.29M in Q4 2025.
- How has BioMarin Pharmaceuticals's ireland — total long-lived assets changed year-over-year?
- BioMarin Pharmaceuticals's ireland — total long-lived assets increased by 7.5% year-over-year, from $308.12M to $331.29M.
- What does ireland — total long-lived assets mean?
- The total value of long-term assets held by the company in Ireland.
- How do you interpret ireland — total long-lived assets?
- An increase suggests significant capital investment in regional manufacturing or R&D infrastructure, while a decrease may indicate asset divestiture, impairment, or depreciation of existing facilities.
- How does ireland — total long-lived assets compare across companies?
- Comparable to geographic property, plant, and equipment (PP&E) disclosures found in the notes to consolidated financial statements of multinational pharmaceutical peers.